Clinical Trials Browser

Terminated × ARQ 197 × Thoracic × Clear all

NCT01244191 2021-04-06

Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer

Phase 3 Terminated

1,048 enrolled 15 charts

Carcinoma, Non-Small-Cell Lung

NCT01377376 2016-12-07

ATTENTION

Phase 3 Terminated

Carcinoma, Non-Small-Cell Lung

NCT01861301 2016-10-24

Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma

Phase 2 Terminated

18 enrolled 7 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural